SCHEMBL6503200

SCHEMBL6503200

COC(=O)C(C)NC(=O)C1CCN(C(=O)/C=C/c2ccc(N(C)C)c([N+](=O)[O-])c2)CC1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ITGB2 P05107 8/20 0.49
ICAM1 P05362 8/20 0.49
ITGAL P20701 8/20 0.49
CAPN1 P07384 3/20 0.47
ALDH1A1 P00352 4/20 0.46
NPC1 O15118 4/20 0.46
RAB9A P51151 4/20 0.46
MAPT P10636 3/20 0.46
LMNA P02545 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
HPGD P15428 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
MAPK1 P28482 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6503201 1.00 ITGB2 (0.49) ITGB2ICAM1ITGALCAPN1ALDH1A1
SCHEMBL6498627 0.92 ITGB2 (0.51) ITGB2ICAM1ITGALCAPN1ALDH1A1
SCHEMBL8296927 0.92 ITGB2 (0.51) ITGB2ICAM1ITGALCAPN1ALDH1A1
SCHEMBL6498635 0.92 ITGB2 (0.51) ITGB2ICAM1ITGALCAPN1ALDH1A1
SCHEMBL6498794 0.87 CAPN1 (0.49) CAPN1ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL6498797 0.87 CAPN1 (0.49) CAPN1ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL6498757 0.84 CAPN1 (0.47) ITGB2ICAM1ITGALCAPN1ALDH1A1
SCHEMBL6498751 0.84 CAPN1 (0.47) ITGB2ICAM1ITGALCAPN1ALDH1A1
SCHEMBL6494761 0.80 ITGB2 (0.53) ITGB2ICAM1ITGALCAPN1ALDH1A1
SCHEMBL6494765 0.80 ITGB2 (0.53) ITGB2ICAM1ITGALCAPN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed